Armour Residential REIT, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Armour Residential REIT, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $322.69M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | ($14.39M) | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | ($67.92M) | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | ($229.93M) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $15.36M | Mar 15, 2024 |
| FY2020 | Dec 31, 2020 | $81.41M | Feb 17, 2021 |
| FY2020 | Sep 30, 2020 | $58.39M | Feb 17, 2021 |
| FY2020 | Jun 30, 2020 | $51.75M | Feb 17, 2021 |
| FY2020 | Mar 31, 2020 | ($406.66M) | Feb 17, 2021 |
| FY2020 | Dec 31, 2019 | $108.68M | Feb 17, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $124.20M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $261.46M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $132.82M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $124.09M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $11.74M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | ($257.82M) | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | ($40.72M) | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $75.22M | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $110.08M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | ($203.43M) | Feb 14, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.01B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $13.55B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $12.34B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $9.44B | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $5.28B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $5.52B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $13.27B | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $8.46B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $8.93B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $7.98B | Feb 14, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.74B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $12.19B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $11.07B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $8.32B | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $4.13B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $4.59B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $11.84B | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $7.34B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $7.60B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $6.89B | Feb 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.26B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $1.36B | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $1.27B | Feb 18, 2026 |
| FY2025 | Dec 31, 2022 | $1.11B | Feb 18, 2026 |
| FY2024 | Dec 31, 2021 | $1.14B | Feb 12, 2025 |
| FY2023 | Dec 31, 2020 | $938.30M | Mar 15, 2024 |
| FY2022 | Dec 31, 2019 | $1.44B | Feb 15, 2023 |
| FY2021 | Dec 31, 2018 | $1.13B | Feb 16, 2022 |
| FY2020 | Dec 31, 2017 | $1.33B | Feb 17, 2021 |
| FY2019 | Dec 31, 2016 | $1.09B | Feb 19, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($518.17M) | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | ($840.85M) | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | ($826.46M) | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | ($758.54M) | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | ($528.61M) | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | ($2.27B) | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | ($1.97B) | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | ($1.58B) | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | ($1.36B) | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | ($1.44B) | Feb 14, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $63.27M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $67.97M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $221.89M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $87.28M | Mar 15, 2024 |
| FY2017 | Dec 31, 2017 | $265.23M | Feb 14, 2018 |
| FY2017 | Dec 31, 2016 | $271.77M | Feb 14, 2018 |
| FY2017 | Dec 31, 2015 | $289.93M | Feb 14, 2018 |
| FY2017 | Dec 31, 2014 | $494.56M | Feb 14, 2018 |
| FY2016 | Dec 31, 2013 | $496.48M | Feb 15, 2017 |
| FY2015 | Dec 31, 2012 | $771.28M | Feb 18, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | (10) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 15, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 17, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Mar 31, 2020 | (6) | Feb 17, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 17, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | (10) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 15, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 17, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Mar 31, 2020 | (6) | Feb 17, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 17, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 111.92M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 62.41M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | 48.80M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | 32.58M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | 94.15M | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | 65.29M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | 58.88M | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | 43.70M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | 41.88M | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | 36.72M | Feb 14, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $271.42M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $150.95M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $216.19M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $142.42M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $96.63M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $75.49M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $124.48M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $97.02M | Feb 17, 2021 |
| FY2018 | Dec 27, 2018 | $8.31M | Feb 14, 2019 |
| FY2018 | Nov 27, 2018 | $8.12M | Feb 14, 2019 |